世界のスマートインスリンペンおよびポンプの市場規模は2023年に69億3000万ドルと評価され、2024年から2030年にかけて8.4%のCAGR)で成長すると予測されます。座りがちな生活習慣、糖尿病の管理と予防に対する患者の関心の高まり、医療技術の進歩により、世界の若年人口の間で糖尿病の有病率が上昇していることが、市場の成長を牽引する主な要因です。1型糖尿病の患者や、まれに2型糖尿病の患者は、血糖値を最適なレベルに保つためにインスリンが必要です。接続性の向上、データ管理機能、投与精度の向上など、インスリン送達デバイスの継続的な技術革新が、この市場の需要を促進するのに貢献しています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Smart Insulin Pens & Pumps Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Smart Insulin Pens & Pumps Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
Chapter 4. Smart Insulin Pens & Pumps Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Smart Insulin Pens & Pumps Market: Type Movement Analysis, USD Million, 2023 & 2030
4.3. Smart Insulin Pens
4.3.1. Smart Insulin Pens Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Companion Medical (InPen)
4.3.2.1. Companion Medical (InPen) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Novo Nordisk (NovoPen 6 & NovoPen Echo)
4.3.3.1. Novo Nordisk (NovoPen 6 & NovoPen Echo) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Emperra Gmbh (ESYSTA Pen)
4.3.4.1. Emperra Gmbh (ESYSTA Pen) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. pendiq intelligent diabetes care (pendiq 2.0)
4.3.5.1. pendiq intelligent diabetes care (pendiq 2.0) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Smart Insulin Pumps
4.4.1. Smart Insulin Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. MiniMed (630G and 670G)
4.4.2.1. MiniMed (630G and 670G) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Accu-Chek (Combo and Insight)
4.4.3.1. Accu-Chek (Combo and Insight) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Tandem (t:slim X2, t:slim G4)
4.4.4.1. Tandem (t:slim X2, t:slim G4) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Insulet (Omnipod)
4.4.5.1. Insulet (Omnipod) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.6. myLife Omnipod
4.4.6.1. myLife Omnipod Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.7. Others
4.4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Smart Insulin Pens & Pumps Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Smart Insulin Pens & Pumps Market: End Use Movement Analysis, USD Million, 2023 & 2030
5.3. Hospitals and Clinics
5.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Homecare
5.4.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Smart Insulin Pens & Pumps Market: Regional Estimates & Trend Analysis
6.1. Smart Insulin Pens & Pumps Market Share, By Region, 2023 & 2030, USD Million
6.2. North America
6.2.1. North America Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.2. U.S.
6.2.2.1. U.S. Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.3. Canada
6.2.3.1. Canada Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2.4. Mexico
6.2.4.1. Mexico Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
6.3.1. Europe Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.2. U.K.
6.3.2.1. U.K. Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.3. Germany
6.3.3.1. Germany Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.4. France
6.3.4.1. France Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.5. Italy
6.3.5.1. Italy Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.6. Spain
6.3.6.1. Spain Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.7. Denmark
6.3.7.1. Denmark Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.8. Sweden
6.3.8.1. Sweden Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3.9. Norway
6.3.9.1. Norway Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
6.4.1. Asia Pacific Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. China
6.4.2.1. China Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Japan
6.4.3.1. Japan Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.4. India
6.4.4.1. India Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.5. South Korea
6.4.5.1. South Korea Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.6. Australia
6.4.6.1. Australia Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.7. Thailand
6.4.7.1. Thailand Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
6.5.1. Latin America Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. Brazil
6.5.2.1. Brazil Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Argentina
6.5.3.1. Argentina Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East and Africa
6.6.1. Middle East and Africa Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. Saudi Arabia
6.6.2.1. Saudi Arabia Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. South Africa
6.6.3.1. South Africa Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. UAE
6.6.4.1. UAE Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Kuwait
6.6.5.1. Kuwait Smart Insulin Pens & Pumps Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
7.4.1. Novo Nordisk A/S
7.4.1.1. Participant’s Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Recent Developments/ Strategic Initiatives
7.4.2. Sanofi
7.4.2.1. Participant’s Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Recent Developments/ Strategic Initiatives
7.4.3. Insulet Corporation
7.4.3.1. Participant’s Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Recent Developments/ Strategic Initiatives
7.4.4. Medtronic
7.4.4.1. Participant’s Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Recent Developments/ Strategic Initiatives
7.4.5. Abbott
7.4.5.1. Participant’s Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Recent Developments/ Strategic Initiatives
7.4.6. Lilly
7.4.6.1. Participant’s Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Recent Developments/ Strategic Initiatives
7.4.7. F. Hoffmann-La Roche Ltd
7.4.7.1. Participant’s Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Recent Developments/ Strategic Initiatives
7.4.8. Emperra GmbH E-Health Technologies
7.4.8.1. Participant’s Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Recent Developments/ Strategic Initiatives
7.4.9. YPSOMED
7.4.9.1. Participant’s Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Recent Developments/ Strategic Initiatives
7.4.10. Tandem Diabetes Care, Inc.
7.4.10.1. Participant’s Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Recent Developments/ Strategic Initiatives
7.4.11. Cambridge Consultants
7.4.11.1. Participant’s Overview
7.4.11.2. Financial Performance
7.4.11.3. Product Benchmarking
7.4.11.4. Recent Developments/ Strategic Initiatives
7.4.12. pendiq
7.4.12.1. Participant’s Overview
7.4.12.2. Financial Performance
7.4.12.3. Product Benchmarking
7.4.12.4. Recent Developments/ Strategic Initiatives
7.4.13. SOOIL Developments Co., Ltd
7.4.13.1. Participant’s Overview
7.4.13.2. Financial Performance
7.4.13.3. Product Benchmarking
7.4.13.4. Recent Developments/ Strategic Initiatives
7.4.14. DUKADA
7.4.14.1. Participant’s Overview
7.4.14.2. Financial Performance
7.4.14.3. Product Benchmarking
7.4.14.4. Recent Developments/ Strategic Initiatives
7.4.15. delfu-medical.com
7.4.15.1. Participant’s Overview
7.4.15.2. Financial Performance
7.4.15.3. Product Benchmarking
7.4.15.4. Recent Developments/ Strategic Initiatives
